(NBIX) Neurocrine Biosciences - Performance -23.9% in 12m
Compare NBIX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
5.70%
#35 in Group
Rel. Strength
26.05%
#5908 in Universe
Total Return 12m
-23.88%
#71 in Group
Total Return 5y
3.63%
#39 in Group
P/E 30.8
73th Percentile in Group
P/E Forward 20.4
69th Percentile in Group
PEG 0.27
67th Percentile in Group
FCF Yield 5.92%
91th Percentile in Group
12m Total Return: NBIX (-23.9%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-8.45% | 25.1% | 163% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
3.06% | 25.7% | 43.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-11.4% | 5.51% | 37.4% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
| LONN SW Lonza |
-3.34% | 9.2% | 33.3% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-3.25% | 13.2% | -1.03% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-12% | -23.9% | 3.63% | 30.8 | 20.4 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-8.87% | 30.5% | -10.1% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
| ERF PA Eurofins Scientific SE |
-2.43% | -17.2% | 17.1% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: NBIX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NBIX
| Total Return (including Dividends) | NBIX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -11.99% | -12.59% | -8.16% |
| 3 Months | -30.68% | -14.87% | -12.80% |
| 12 Months | -23.88% | -7.16% | 6.85% |
| 5 Years | 3.63% | -19.64% | 100.40% |
| Trend Score (consistency of price movement) | NBIX | XBI | S&P 500 |
| 1 Month | -67.3% | -66.6% | -70.9% |
| 3 Months | -90.7% | -92.4% | -90.1% |
| 12 Months | -54.2% | -30.3% | 62.2% |
| 5 Years | 51.0% | -53.2% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #101 | 0.68% | -4.17% |
| 3 Month | #122 | -18.6% | -20.5% |
| 12 Month | #70 | -18.0% | -28.8% |
| 5 Years | #39 | 29.0% | -48.3% |
FAQs
Does NBIX Neurocrine Biosciences outperforms the market?
No,
over the last 12 months NBIX made -23.88%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months NBIX made -30.68%, while XBI made -14.87%.
Over the last 3 months NBIX made -30.68%, while XBI made -14.87%.
Performance Comparison NBIX vs Indeces and Sectors
NBIX vs. Indices NBIX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 7.73% | -3.83% | -3.84% | -30.7% |
| US NASDAQ 100 | QQQ | 8.75% | -2.58% | -2.78% | -30.7% |
| US Dow Jones Industrial 30 | DIA | 8.68% | -4.13% | -4.87% | -28.0% |
| German DAX 40 | DAX | 5.64% | -5.13% | -22.3% | -42.4% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.11% | -8.26% | -6.26% | -32.0% |
| Hongkong Hang Seng | HSI | 2.68% | -7.03% | -8.48% | -41.2% |
| India NIFTY 50 | INDA | 1.16% | -14.6% | -9.82% | -27.7% |
| Brasil Bovespa | EWZ | 1.78% | -10.7% | -9.17% | -14.0% |
NBIX vs. Sectors NBIX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 7.57% | -3.67% | -12.9% | -38.9% |
| Consumer Discretionary | XLY | 7.25% | -3.12% | -7.74% | -34.0% |
| Consumer Staples | XLP | 4.31% | -15.6% | -14.5% | -36.2% |
| Energy | XLE | 2.84% | 0.35% | -4.50% | -11.8% |
| Financial | XLF | 6.03% | -6.03% | -13.7% | -41.1% |
| Health Care | XLV | 7.71% | -3.77% | -3.01% | -22.3% |
| Industrial | XLI | 7.16% | -4.80% | -4.52% | -28.1% |
| Materials | XLB | 5.12% | -6.03% | 1.49% | -17.0% |
| Real Estate | XLRE | 4.34% | -8.64% | -6.56% | -39.5% |
| Technology | XLK | 10.0% | -0.42% | 3.79% | -23.7% |
| Utilities | XLU | 5.39% | -11.8% | -10.3% | -45.6% |
| Aerospace & Defense | XAR | 8.09% | -6.62% | -12.6% | -45.1% |
| Biotech | XBI | 4.36% | 0.60% | 8.11% | -16.7% |
| Homebuilder | XHB | 4.60% | -4.01% | 8.89% | -15.9% |
| Retail | XRT | 3.52% | -6.37% | -1.91% | -19.4% |